What is EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL used for?

( ARTG ) Evrysdi is indicated for the treatment of 5q spinal muscular atrophy (SMA)

What are the side effects of EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL be used during pregnancy?

( AHT ) For the active ingredient risdiplam You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

OTC

EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL

INN: EVRYSDI

Data updated: 2026-04-11

Available in:

🇩🇪🇬🇧🇪🇸

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Roche Registration Gmbh

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.